Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2025
Reporting Period: Single event date (November 12, 2025)
Business Context: The registrant is a Delaware corporation with principal executive offices in Wixom, Michigan. Its common stock is registered on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate presentation rather than a financial statement.
Material Changes
No material financial changes or operational events are detailed within the text of this filing. The sole material event reported is the release of an updated corporate presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: On November 12, 2025, the company made an updated corporate presentation available to the public.
- Exhibit Reference: The presentation is included as Exhibit 99.1.
- Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation dated November 12, 2025) for specific financial guidance, strategic updates, and operational metrics not contained in this summary.
- Verify the trading status of RMTI on the Nasdaq Capital Market.
- Note that the content of the corporate presentation is not legally "filed" under Section 18 of the Exchange Act, which may impact liability standards for the information presented.